lactobacillus casei
Cell therapyexperimental
Lacticaseibacillus casei is an organism that belongs to the largest genus in the family Lactobacillaceae, a lactic acid bacteria (LAB), that was previously classified as Lactobacillus casei. This bacteria has been identified as facultatively anaerobic or microaerophilic, acid-tolerant, non-spore-forming bacteria. — Wikipedia
Clinical trial activity
177 trials · 211 clinical orgs · 0 marketing orgs
Phase 1
13
Phase 2
38
Phase 3
27
Phase 4
22
Earliest trial started Aug 1, 2000 (NCT00894816)
Timeline
Indications
Approved for
Studied for
- Acute-On-Chronic Liver Failure · Phase 2/Phase 3
- Adenomatous Polyposis Coli · Phase 2
- Allergy and Immunology · Phase 2
- Ascites · Phase 2
- Asthma · Phase 2/Phase 3
- Candidiasis, Vulvovaginal · Phase 3
- Cardiovascular Diseases · Phase 1
- Celiac Disease · Phase 4
- Clostridium Infections · Phase 3
- Colonic Neoplasms · Phase 4
- Colonoscopy · Phase 4
- Constipation · Phase 4
- Coronavirus Infections · Phase 2
- COVID-19 · Phase 2
- Crohn Disease · Phase 4
- Deglutition Disorders · Early Phase 1
- Dental Caries · Phase 2/Phase 3
- Dermatitis, Atopic · Phase 4
- Dermatology · Phase 3
- Diabetes Mellitus · Phase 2
- Diarrhea · Phase 4
- Drug Resistance, Bacterial · Phase 2
- Dyslipidemias · Phase 1/Phase 2
- Dyspepsia · Phase 1/Phase 2
- Eczema · Phase 2/Phase 3
- Esophageal and Gastric Varices · Phase 3
- Fatty Liver · Phase 1
- Fibrosis · Phase 3
- Gastroenteritis · Phase 4
- Gastrointestinal Microbiome · Phase 2
- Healthy Volunteers · Phase 3
- Helicobacter pylori · Phase 4
- Hepatic Encephalopathy · Phase 4
- Hirschsprung Disease · Phase 2
- Hyperlipoproteinemia Type II · Phase 1/Phase 2
- Hypersensitivity · Phase 2/Phase 3
- Immune System Diseases · Phase 3
- Inflammation · Phase 2
- Inflammatory Bowel Diseases · Phase 3
- Interleukin-17 · Phase 1/Phase 2
- Intestinal Neoplasms · Phase 4
- Irritable Bowel Syndrome · Phase 4
- Kidney Failure, Chronic · Phase 2
- Klebsiella pneumoniae · Phase 1/Phase 2
- Lactation · Early Phase 1
- Lactobacillus · Phase 3
- Liver Cirrhosis · Phase 2/Phase 3
- Metabolic Syndrome · Phase 4
- Mothers · Early Phase 1
- Non-alcoholic Fatty Liver Disease · Phase 2
- Obesity · Phase 2/Phase 3
- Osteoporosis · Phase 2
- Peritonitis · Phase 2/Phase 3
- Pneumonia, Viral · Phase 2
- Probiotics · Phase 4
- Purpura, Thrombocytopenic, Idiopathic · Phase 2
- Respiratory Tract Infections · Phase 4
- Rhinitis · Phase 3
- Rhinitis, Allergic · Phase 2
- Rhinitis, Allergic, Perennial · Phase 3
- Signs and Symptoms, Digestive · Phase 2
- Stomatitis, Aphthous · Phase 2
- Vaginosis, Bacterial · Phase 3
- Water Loss, Insensible · Phase 3
Mechanism of action
- microbiotaTissue restoration
microbiota tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaLacticaseibacillus casei ↗
- NCATSSA940P2U00 ↗
- WikipediaLactobacillus paracasei ↗
- WikipediaLactobacillus casei ↗
- WikipediaLacticaseibacillus paracasei ↗
Also known as
- heat-treated lactobacillus paracasei
- lactobacillus casei
- lactobacillus casei dg
- lactobacillus casei lbc80r
- lactobacillus casei rhamnosus lcr35
- lactobacillus casei shirota
- lactobacillus casei strain shirota
- lactobacillus casei var. rhamnosus
- lactobacillus casei zhang
- lactobacillus f19
- lactobacillus paracasei
- lactobacillus paracasei b21060
- lactobacillus paracasei f19
- lactobacillus paracasei gmnl-133
- lactobacillus paracasei gmnl-32
- lactobacillus paracasei ha-196
- lactobacillus paracasei impc 2.1 lmgp22043
- lactobacillus paracasei lp-33
- lactobacillus paracasei ncc2461
- lactobacillus paracasei ncc 2461
- lactobacillus paracasei ssp paracasei
- lactobacillus paracasei ssp paracasei f19
- lactobacillus paracasei w20
- lactobacillus rhamnosus lcr35
- lactobacilus casei
- l. casei
- vsl #3
- vsl#3
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07287306 | N/A | Dec 10, 2025 | Wecare Probiotics Co., Ltd. |
| NCT07168824 | N/A | Sep 10, 2025 | Bened Biomedical Co., Ltd., National Taiwan Sport University |
| NCT07165457 | N/A | Sep 4, 2025 | Clinica Universidad de Navarra |
| NCT06970964 | N/A | Aug 21, 2025 | Federal University of Sao Paulo |
| NCT07081100 | N/A | Aug 5, 2025 | Wecare Probiotics Co., Ltd. |
| NCT07017959 | N/A | Jun 15, 2025 | University of South Florida |
| NCT06873438 | N/A | Mar 10, 2025 | Wecare Probiotics Co., Ltd. |
| NCT06720805 | N/A | Dec 1, 2024 | University of Roma La Sapienza |
| NCT06699537 | N/A | Dec 1, 2024 | Wecare Probiotics Co., Ltd. |
| NCT06544278 | N/A | Aug 30, 2024 | Wecare Probiotics Co., Ltd. |
| NCT06470906 | N/A | Aug 14, 2024 | Columbia University |
| NCT06899620 | N/A | Jul 1, 2024 | Wecare Probiotics Co., Ltd. |
| NCT06629441 | N/A | Jun 20, 2024 | Wecare Probiotics Co., Ltd. |
| NCT06607562 | N/A | Jun 3, 2024 | Wecare Probiotics Co., Ltd. |
| NCT07072871 | N/A | Apr 1, 2024 | PT Royal Medikalink Pharmalab |
| NCT05964231 | N/A | Aug 1, 2023 | Mackay Medical College |
| NCT07296718 | Phase 4 | May 15, 2023 | Islamia University of Bahawalpur |
| NCT05674981 | N/A | Apr 24, 2023 | Chung Shan Medical University, GenMont Biotech Incorporation |
| NCT05719649 | N/A | Apr 1, 2023 | SunWay Biotech Co., LTD. |
| NCT05801042 | N/A | Feb 7, 2023 | Orebro University |
Showing 20 of 177 trials
Page 1 / 9
Organizations
Research & Development (211)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Wecare Probiotics Co., Ltd. | For profit | 8 | 8 | 1 | 2024 |
| Yakult Honsha Co., LTD | For profit | 8 | 5 | 3 | 2006 |
| VSL Pharmaceuticals | For profit | 7 | 3 | 4 | 2004 |
| Bened Biomedical Co., Ltd. | For profit | 5 | 0 | 1 | 2019 |
| GenMont Biotech Incorporation | For profit | 5 | 5 | 2 | 2010 |
| Medical University of Graz | Academic/Hospital | 5 | 5 | 1 | 2010 |
| University of Copenhagen | Academic/Hospital | 5 | 4 | 2 | 2003 |
| Danone Research | For profit | 4 | 3 | 2 | 2006 |
| Mackay Medical College | Academic/Hospital | 4 | 4 | 1 | 2019 |
| Nestle | For profit | 4 | 3 | 3 | 2004 |
| SOFAR S.p.A. | For profit | 4 | 4 | 2 | 2012 |
| Bio-K Plus International Inc. | For profit | 3 | 3 | 1 | 2006 |
| NIZO Food Research | For profit | 3 | 0 | 1 | 2008 |
| University of Naples Frederico II | Academic/Hospital | 3 | 3 | 2 | 2012 |
| University of Science Malaysia | Academic/Hospital | 3 | 2 | 3 | 2015 |
| All India Institute of Medical Sciences | Academic/Hospital | 2 | 1 | 1 | 2007 |
| Arla Foods | For profit | 2 | 1 | 1 | 2010 |
| CD Pharma India Pvt. Ltd. | For profit | 2 | 2 | 1 | 2009 |
| Chang Gung University | Academic/Hospital | 2 | 1 | 2 | 2008 |
| Chr Hansen | For profit | 2 | 1 | 2 | 2010 |
211 organizations
Page 1 / 11